Aclaris Therapeutics
ACRS
ACRS
148 hedge funds and large institutions have $579M invested in Aclaris Therapeutics in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
40
Increased
43
Reduced
40
Closed
20
Calls
$26.5M
Puts
$20M
Net Calls
+$6.53M
Net Calls Change
+$6.41M
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
VA
2
VR Adviser
New York
|
$8.42M |
| 3 |
CC
3
Commodore Capital
New York
|
$5.14M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$0 |
| 5 |
TCM
5
TCG Crossover Management
Palo Alto,
California
|
$4.29M |
